schizandrin b has been researched along with concanavalin a in 2 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhilwade, HN; Checker, R; Konishi, T; Menon, J; Patwardhan, RS; Sandur, SK; Sharma, D; Thoh, M | 1 |
| Chan, WM; Chen, J; Ko, KM; Leong, PK; Leung, HY; Wong, HS | 1 |
2 other study(ies) available for schizandrin b and concanavalin a
| Article | Year |
|---|---|
Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB.
Topics: Animals; Anti-Inflammatory Agents; Concanavalin A; Cyclooctanes; Cytokines; Gene Expression Regulation; Heme Oxygenase-1; I-kappa B Kinase; Lignans; Lymphocyte Activation; Lymphocytes; Male; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase Kinases; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Polycyclic Compounds; Proto-Oncogene Proteins p21(ras); Signal Transduction; Spleen | 2012 |
Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Concanavalin A; Cyclooctanes; Cytokines; Edema; Enzyme-Linked Immunosorbent Assay; Female; Glutathione; Glutathione Transferase; Inflammation; Lignans; Lipopolysaccharides; Mice; Mice, Inbred ICR; Polycyclic Compounds; RAW 264.7 Cells | 2016 |